AZACITIDINE FOR

AZACITIDINE FOR was reported 18638 times

AZACITIDINE FOR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FLT3 GENE MUTATION 12 0.8000
1 ACUTE MYELOID LEUKAEMIA REFRACTORY 56 0.3256
2 ALLOGENIC STEM CELL TRANSPLANTATION 50 0.3165
3 PROTOTHECOSIS 25 0.2660
4 EMPHYSEMATOUS CHOLECYSTITIS 13 0.2600
5 CORYNEBACTERIUM BACTERAEMIA 20 0.2353
6 ACUTE MYELOID LEUKAEMIA RECURRENT 462 0.2150
7 ACUTE MYELOID LEUKAEMIA (IN REMISSION) 7 0.2059
8 CORD BLOOD TRANSPLANT THERAPY 17 0.2000
9 JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA 9 0.1765
10 CHIMERISM 14 0.1573
11 BACILLUS BACTERAEMIA 17 0.1560
12 PORTAL VEIN CAVERNOUS TRANSFORMATION 6 0.1463
13 BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA 11 0.1358
14 LOWER MOTOR NEURONE LESION 7 0.1321
15 PARAINFLUENZA VIRUS INFECTION 13 0.1262
16 LEUKOSTASIS SYNDROME 16 0.1203
17 BLAST CELLS 6 0.1154
18 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 71 0.1082
19 MINIMAL RESIDUAL DISEASE 52 0.1077
20 MENINGEAL NEOPLASM 7 0.1045
21 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 9 0.1011
22 DIFFERENTIATION SYNDROME 71 0.0967
23 CLONAL EVOLUTION 10 0.0962
24 MALASSEZIA INFECTION 6 0.0882
25 SEPTAL PANNICULITIS 7 0.0875
26 ACUTE MYELOID LEUKAEMIA 1318 0.0845
27 GEOTRICHUM INFECTION 16 0.0758
28 CONGENITAL APLASIA 23 0.0740
29 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 9 0.0738
30 BLAST CELL COUNT INCREASED 77 0.0735
31 VEXAS SYNDROME 7 0.0729
32 RED BLOOD CELL TRANSFUSION 27 0.0659
33 PNEUMONIA ADENOVIRAL 13 0.0657
34 KARYOTYPE ANALYSIS ABNORMAL 7 0.0642
35 REFRACTORINESS TO PLATELET TRANSFUSION 7 0.0642
36 AEROMONAS INFECTION 12 0.0635
37 ASPIRATION BONE MARROW 8 0.0602
38 ADENOVIRAL HEPATITIS 14 0.0596
39 ASPIRATION BONE MARROW ABNORMAL 8 0.0593
40 HEPATIC INFECTION FUNGAL 7 0.0583
41 CHLOROMA 24 0.0569
42 CHRONIC MYELOMONOCYTIC LEUKAEMIA 36 0.0545
43 BACILLUS INFECTION 34 0.0538
44 SKIN MACERATION 8 0.0523
45 LEUKAEMIA CUTIS 8 0.0519
46 BLOOD PRODUCT TRANSFUSION DEPENDENT 21 0.0499
47 INCARCERATED INGUINAL HERNIA 6 0.0492
48 TISSUE INFILTRATION 14 0.0475
49 MYELOSUPPRESSION 1698 0.0471
50 PLATELET TRANSFUSION 59 0.0458
51 BLAST CELLS PRESENT 22 0.0457
52 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 14 0.0447
53 GRAFT VERSUS HOST DISEASE IN LUNG 21 0.0439
54 ANORECTAL INFECTION 11 0.0437
55 TONSILLITIS BACTERIAL 8 0.0412
56 PNEUMONIA FUNGAL 160 0.0405
57 GRAFT VERSUS HOST DISEASE IN LIVER 29 0.0405
58 GRANULOCYTE COUNT DECREASED 75 0.0404
59 PRIMARY MYELOFIBROSIS 13 0.0404
60 T-CELL TYPE ACUTE LEUKAEMIA 8 0.0392
61 CYTOPENIA 461 0.0376
62 PERIORBITAL CELLULITIS 20 0.0372
63 TUMOUR LYSIS SYNDROME 315 0.0358
64 ANAL INFECTION 9 0.0350
65 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 7 0.0345
66 PSEUDOMONAL BACTERAEMIA 29 0.0340
67 MYELOID LEUKAEMIA 16 0.0319
68 ACUTE MYELOMONOCYTIC LEUKAEMIA 8 0.0317
69 RHINOCEREBRAL MUCORMYCOSIS 11 0.0317
70 STENOTROPHOMONAS INFECTION 43 0.0317
71 FEBRILE NEUTROPENIA 2057 0.0310
72 TOXIC NEUROPATHY 12 0.0305
73 ENTEROBACTER BACTERAEMIA 9 0.0297
74 SOFT TISSUE INFECTION 51 0.0278
75 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 7 0.0275
76 MYELODYSPLASTIC SYNDROME TRANSFORMATION 14 0.0269
77 KLEBSIELLA BACTERAEMIA 25 0.0263
78 SINUSITIS FUNGAL 21 0.0262
79 CENTRAL NERVOUS SYSTEM LEUKAEMIA 10 0.0254
80 SYSTEMIC CANDIDA 62 0.0247
81 TUMOUR ASSOCIATED FEVER 10 0.0244
82 FUSARIUM INFECTION 17 0.0243
83 PACKED RED BLOOD CELL TRANSFUSION 32 0.0242
84 NEUTROPENIC COLITIS 50 0.0242
85 MYELOPROLIFERATIVE NEOPLASM 16 0.0241
86 GRAFT VERSUS HOST DISEASE IN SKIN 53 0.0240
87 TRANSPLANT 56 0.0236
88 MYELODYSPLASTIC SYNDROME 341 0.0236
89 INTRACRANIAL TUMOUR HAEMORRHAGE 9 0.0233
90 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 54 0.0232
91 KLEBSIELLA SEPSIS 26 0.0231
92 BRONCHOPULMONARY ASPERGILLOSIS 178 0.0229
93 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 63 0.0228
94 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 16 0.0223
95 FEBRILE INFECTION 26 0.0221
96 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 10 0.0215
97 TRANSPLANTATION COMPLICATION 9 0.0214
98 PALLIATIVE CARE 31 0.0202
99 ESCHERICHIA BACTERAEMIA 47 0.0200
100 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 7 0.0199
101 DISEASE RISK FACTOR 8 0.0199
102 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 28 0.0198
103 PULMONARY SEPSIS 28 0.0192
104 GASTRIC VARICES 9 0.0191
105 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 25 0.0190
106 ESCHERICHIA SEPSIS 54 0.0186
107 INFECTIVE ANEURYSM 9 0.0182
108 LOWER RESPIRATORY TRACT INFECTION FUNGAL 7 0.0180
109 PRODUCT RECONSTITUTION QUALITY ISSUE 16 0.0179
110 ENDOCARDITIS BACTERIAL 14 0.0178
111 SPLENIC INFARCTION 31 0.0178
112 STREPTOCOCCAL BACTERAEMIA 19 0.0175
113 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 37 0.0174
114 BACTERIAL SEPSIS 56 0.0172
115 PULMONARY MUCORMYCOSIS 9 0.0170
116 LICHENIFICATION 7 0.0170
117 HAEMATOTOXICITY 162 0.0170
118 ENTEROCOCCUS TEST POSITIVE 11 0.0170
119 NEUTROPENIC SEPSIS 121 0.0169
120 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 14 0.0166
121 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 6 0.0165
122 ANGIODYSPLASIA 6 0.0165
123 STEM CELL TRANSPLANT 41 0.0164
124 ENTEROBACTER SEPSIS 6 0.0162
125 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 15 0.0162
126 MONOCYTOSIS 10 0.0161
127 PSEUDOMONAL SEPSIS 28 0.0160
128 TRANSFUSION REACTION 14 0.0160
129 LEUKAEMIA RECURRENT 27 0.0160
130 APLASIA 31 0.0158
131 BONE MARROW TRANSPLANT 30 0.0158
132 HYPERLEUKOCYTOSIS 14 0.0158
133 IRON OVERLOAD 17 0.0157
134 SCEDOSPORIUM INFECTION 11 0.0156
135 ACUTE LEUKAEMIA 25 0.0155
136 MUCORMYCOSIS 40 0.0154
137 KLEBSIELLA TEST POSITIVE 10 0.0154
138 DISSEMINATED MUCORMYCOSIS 6 0.0152
139 BIOPSY BONE MARROW 7 0.0150
140 BLOOD IMMUNOGLOBULIN A INCREASED 8 0.0148
141 BACTERAEMIA 175 0.0147
142 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 9 0.0147
143 BLOOD BILIRUBIN DECREASED 9 0.0146
144 SYSTEMIC MYCOSIS 17 0.0146
145 HAEMOPHILUS INFECTION 14 0.0143
146 BRAIN ABSCESS 36 0.0142
147 ENTEROCOCCAL BACTERAEMIA 15 0.0142
148 PNEUMONIA KLEBSIELLA 26 0.0141
149 INVESTIGATION ABNORMAL 20 0.0139
150 FEBRILE BONE MARROW APLASIA 59 0.0139
151 ENTEROCOCCAL INFECTION 66 0.0136
152 ENGRAFTMENT SYNDROME 8 0.0135
153 BONE MARROW DISORDER 40 0.0132
154 MARROW HYPERPLASIA 9 0.0132
155 GRAFT VERSUS HOST DISEASE 94 0.0131
156 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 12 0.0130
157 ASPERGILLUS INFECTION 85 0.0129
158 REMISSION NOT ACHIEVED 8 0.0129
159 ARTHRITIS REACTIVE 8 0.0128
160 FUNGAEMIA 20 0.0127
161 VIRAL HAEMORRHAGIC CYSTITIS 9 0.0126
162 NEUTROPENIC INFECTION 12 0.0125
163 DYSPLASIA 15 0.0125
164 CHRONIC GRAFT VERSUS HOST DISEASE 44 0.0122
165 LUNG CONSOLIDATION 34 0.0121
166 ACUTE GRAFT VERSUS HOST DISEASE 55 0.0120
167 POLYARTERITIS NODOSA 7 0.0120
168 STAPHYLOCOCCAL BACTERAEMIA 52 0.0120
169 DILATED CARDIOMYOPATHY 12 0.0119
170 PARAINFLUENZAE VIRUS INFECTION 18 0.0118
171 NEUTROPHIL COUNT DECREASED 482 0.0118
172 OESOPHAGEAL ULCER HAEMORRHAGE 6 0.0118
173 PANCYTOPENIA 657 0.0117
174 SOFT TISSUE NECROSIS 8 0.0116
175 MYOPERICARDITIS 9 0.0115
176 KLEBSIELLA INFECTION 58 0.0115
177 ENTEROCOCCAL SEPSIS 9 0.0111
178 GENE MUTATION 22 0.0111
179 RENAL TUBULAR DISORDER 31 0.0110
180 FUNGAL SEPSIS 9 0.0108
181 LOCAL REACTION 8 0.0108
182 NEUTROPENIA 1457 0.0107
183 JC VIRUS INFECTION 17 0.0106
184 GINGIVAL ULCERATION 8 0.0106
185 NECROTISING FASCIITIS 37 0.0105
186 STAPHYLOCOCCAL SEPSIS 50 0.0101
187 MUCOSAL DISORDER 10 0.0101
188 PNEUMONIA MYCOPLASMAL 8 0.0101
189 ESCHERICHIA TEST POSITIVE 12 0.0100
190 VENOOCCLUSIVE DISEASE 25 0.0100
191 MYELOFIBROSIS 30 0.0099
192 HAEMATOLOGICAL INFECTION 24 0.0098
193 MUSCLE ABSCESS 6 0.0096
194 SEPTIC EMBOLUS 8 0.0096
195 THROMBOCYTOPENIA 1069 0.0095
196 PERIPHERAL SENSORIMOTOR NEUROPATHY 12 0.0095
197 CYTOMEGALOVIRUS INFECTION REACTIVATION 42 0.0095
198 COLONIC ABSCESS 8 0.0094
199 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 70 0.0093
200 VASCULAR PURPURA 13 0.0093
201 NECROTISING MYOSITIS 8 0.0092
202 VENOOCCLUSIVE LIVER DISEASE 44 0.0089
203 ABSCESS NECK 6 0.0089
204 CYTOGENETIC ABNORMALITY 10 0.0089
205 SEPTIC SHOCK 383 0.0088
206 LUNG OPACITY 23 0.0087
207 ORGANISING PNEUMONIA 43 0.0087
208 ENTEROCOLITIS INFECTIOUS 8 0.0087
209 NEUTROPHIL COUNT ABNORMAL 24 0.0085
210 PLATELET DISORDER 21 0.0083
211 SUPERFICIAL VEIN THROMBOSIS 7 0.0083
212 TRANSFUSION 87 0.0083
213 OESOPHAGEAL CANDIDIASIS 33 0.0083
214 CAROTID ARTERY THROMBOSIS 7 0.0082
215 OTOTOXICITY 15 0.0081
216 ENTEROVIRUS INFECTION 7 0.0081
217 GRANULOCYTOPENIA 46 0.0081
218 LIVER ABSCESS 26 0.0080
219 LEUKAEMIA 75 0.0079
220 PSEUDOMONAS INFECTION 68 0.0079
221 ANAL ABSCESS 42 0.0078
222 CHONDROCALCINOSIS PYROPHOSPHATE 6 0.0078
223 BLOOD DISORDER 61 0.0076
224 AGRANULOCYTOSIS 140 0.0075
225 PYODERMA GANGRENOSUM 27 0.0075
226 URINARY TRACT INFECTION ENTEROCOCCAL 7 0.0075
227 BONE MARROW FAILURE 151 0.0074
228 CATHETER SITE INFECTION 28 0.0074
229 HAEMORRHAGIC DISORDER 8 0.0074
230 ATYPICAL PNEUMONIA 22 0.0073
231 GINGIVAL HYPERTROPHY 11 0.0072
232 URINARY TRACT OBSTRUCTION 17 0.0072
233 MULTIPLE ORGAN DYSFUNCTION SYNDROME 201 0.0071
234 FULL BLOOD COUNT DECREASED 142 0.0070
235 INFECTION REACTIVATION 8 0.0070
236 INTESTINAL ULCER 11 0.0069
237 CLOSTRIDIUM DIFFICILE COLITIS 73 0.0069
238 ACUTE PROMYELOCYTIC LEUKAEMIA 7 0.0068
239 PNEUMOCYSTIS JIROVECII INFECTION 8 0.0067
240 COVID-19 PNEUMONIA 79 0.0067
241 CYTOGENETIC ANALYSIS ABNORMAL 7 0.0067
242 STAPHYLOCOCCUS TEST POSITIVE 14 0.0066
243 PNEUMONITIS 176 0.0065
244 SUBDURAL HAEMATOMA 92 0.0064
245 DISSEMINATED INTRAVASCULAR COAGULATION 90 0.0064
246 LEUKOCYTOSIS 113 0.0062
247 MYOSITIS 56 0.0062
248 CYSTITIS HAEMORRHAGIC 25 0.0062
249 CRYPTOCOCCOSIS 10 0.0061
250 SERONEGATIVE ARTHRITIS 7 0.0061
251 OBLITERATIVE BRONCHIOLITIS 8 0.0061
252 CYTOMEGALOVIRUS COLITIS 14 0.0061
253 GASTROINTESTINAL TOXICITY 29 0.0060
254 PLATELET COUNT DECREASED 642 0.0060
255 SEPSIS 671 0.0060
256 CARDIAC TAMPONADE 28 0.0059
257 ENTEROCOLITIS 34 0.0059
258 SIALOADENITIS 8 0.0059
259 ADENOVIRUS INFECTION 17 0.0059
260 HEPATOSPLENOMEGALY 15 0.0058
261 PSEUDOMEMBRANOUS COLITIS 13 0.0058
262 CAPILLARY LEAK SYNDROME 12 0.0058
263 PLATELET COUNT ABNORMAL 35 0.0058
264 ENCEPHALITIS VIRAL 7 0.0057
265 HAEMOGLOBIN ABNORMAL 37 0.0057
266 PERICARDITIS 96 0.0057
267 ESCHERICHIA INFECTION 47 0.0057
268 PNEUMONIA BACTERIAL 52 0.0057
269 PHLEBITIS 29 0.0057
270 POLYOMAVIRUS VIRAEMIA 6 0.0056
271 HYPERPHOSPHATAEMIA 12 0.0056
272 BONE NEOPLASM 6 0.0056
273 LABELLED DRUG-DRUG INTERACTION ISSUE 8 0.0055
274 WHITE BLOOD CELL COUNT ABNORMAL 35 0.0055
275 DERMATITIS EXFOLIATIVE GENERALISED 19 0.0055
276 EPSTEIN-BARR VIRAEMIA 6 0.0054
277 CHOLESTATIC LIVER INJURY 12 0.0054
278 BLOOD CULTURE POSITIVE 16 0.0053
279 MYOCARDIAL INJURY 6 0.0053
280 MIXED LIVER INJURY 16 0.0053
281 PNEUMOCYSTIS JIROVECII PNEUMONIA 53 0.0053
282 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 14 0.0053
283 ARTHRITIS BACTERIAL 21 0.0051
284 PROCALCITONIN INCREASED 6 0.0051
285 CLOSTRIDIAL INFECTION 17 0.0050
286 CLOSTRIDIUM TEST POSITIVE 11 0.0050
287 PERIPHERAL ARTERY THROMBOSIS 7 0.0050
288 BACTERIAL TEST POSITIVE 11 0.0049
289 MONOCYTE COUNT DECREASED 6 0.0049
290 WHITE BLOOD CELL COUNT DECREASED 528 0.0049
291 INFECTION 705 0.0049
292 ERYTHEMA NODOSUM 17 0.0048
293 ACUTE PULMONARY OEDEMA 27 0.0048
294 SECOND PRIMARY MALIGNANCY 40 0.0048
295 ENTEROCOLITIS HAEMORRHAGIC 7 0.0047
296 HYPERBILIRUBINAEMIA 49 0.0047
297 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 24 0.0047
298 GASTRITIS HAEMORRHAGIC 7 0.0047
299 DISSEMINATED TUBERCULOSIS 12 0.0047
300 SUPERINFECTION 7 0.0047
301 LUNG INFILTRATION 41 0.0046
302 ANAEMIA 885 0.0046
303 THROMBOCYTOSIS 17 0.0046
304 ENDOCARDITIS 23 0.0045
305 EPSTEIN-BARR VIRUS INFECTION 28 0.0045
306 DEVICE RELATED SEPSIS 9 0.0045
307 APLASTIC ANAEMIA 23 0.0044
308 URINARY TRACT INFECTION BACTERIAL 11 0.0043
309 SUBILEUS 9 0.0043
310 IMMUNODEFICIENCY 64 0.0043
311 PROCTITIS 12 0.0043
312 PULMONARY ALVEOLAR HAEMORRHAGE 24 0.0043
313 DISCOURAGEMENT 10 0.0043
314 SPLENOMEGALY 50 0.0043
315 INFLAMMATORY MARKER INCREASED 21 0.0042
316 SKIN INFECTION 47 0.0042
317 BK VIRUS INFECTION 14 0.0041
318 GUILLAIN-BARRE SYNDROME 20 0.0041
319 LYMPHADENITIS 10 0.0041
320 WHITE BLOOD CELL DISORDER 11 0.0041
321 RHINOVIRUS INFECTION 16 0.0041
322 NON-CARDIAC CHEST PAIN 13 0.0041
323 PARONYCHIA 18 0.0041
324 TRANSPLANT FAILURE 10 0.0041
325 BLOOD CREATININE ABNORMAL 14 0.0040
326 HAEMORRHAGE INTRACRANIAL 60 0.0040
327 MENINGITIS CRYPTOCOCCAL 7 0.0040
328 SERUM FERRITIN INCREASED 21 0.0040
329 INFECTIOUS PLEURAL EFFUSION 6 0.0039
330 HAEMORRHAGE URINARY TRACT 10 0.0039
331 ENDOTRACHEAL INTUBATION 11 0.0039
332 ABDOMINAL INFECTION 10 0.0039
333 RESPIRATORY SYNCYTIAL VIRUS INFECTION 34 0.0039
334 CALCULUS URINARY 6 0.0039
335 DIVERTICULAR PERFORATION 8 0.0039
336 PHYSICAL DECONDITIONING 10 0.0039
337 ATRIAL FLUTTER 31 0.0039
338 RESPIRATORY FAILURE 283 0.0039
339 DISEASE PROGRESSION 458 0.0039
340 CARDIOPULMONARY FAILURE 15 0.0038
341 SINUS NODE DYSFUNCTION 7 0.0038
342 PERICARDIAL EFFUSION 88 0.0038
343 BODY TEMPERATURE ABNORMAL 7 0.0038
344 ECCHYMOSIS 26 0.0038
345 VASCULAR DEVICE INFECTION 17 0.0037
346 LEUKOPENIA 187 0.0037
347 PATHOGEN RESISTANCE 34 0.0037
348 HYPOALBUMINAEMIA 29 0.0037
349 BLOOD PHOSPHORUS INCREASED 10 0.0037
350 PNEUMONIA CYTOMEGALOVIRAL 7 0.0036
351 THERAPY NON-RESPONDER 162 0.0036
352 CARDIAC FAILURE ACUTE 24 0.0036
353 CYTOMEGALOVIRUS VIRAEMIA 16 0.0036
354 FULL BLOOD COUNT ABNORMAL 38 0.0036
355 PULMONARY HAEMORRHAGE 28 0.0036
356 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 29 0.0035
357 IMMUNOSUPPRESSION 31 0.0035
358 AUTOIMMUNE HAEMOLYTIC ANAEMIA 12 0.0035
359 FUNGAL SKIN INFECTION 14 0.0035
360 CHEMOTHERAPY 13 0.0034
361 SUBARACHNOID HAEMORRHAGE 35 0.0034
362 LEFT VENTRICULAR DYSFUNCTION 23 0.0034
363 ATELECTASIS 33 0.0034
364 PULMONARY TOXICITY 24 0.0034
365 HISTOPLASMOSIS 6 0.0034
366 MUCOSAL INFLAMMATION 88 0.0034
367 CONGESTIVE CARDIOMYOPATHY 14 0.0034
368 PNEUMONIA 1084 0.0033
369 HOSPICE CARE 33 0.0033
370 ACUTE RESPIRATORY FAILURE 64 0.0033
371 HYPOKALAEMIA 152 0.0033
372 ABSCESS LIMB 14 0.0033
373 BACTERIAL INFECTION 61 0.0033
374 THERAPY PARTIAL RESPONDER 51 0.0033
375 LYMPHOCYTOSIS 7 0.0032
376 FIBROSIS 10 0.0032
377 HEPATIC ENZYME ABNORMAL 16 0.0032
378 BLOOD IRON INCREASED 6 0.0032
379 INFECTION SUSCEPTIBILITY INCREASED 7 0.0032
380 CANDIDA INFECTION 54 0.0032
381 LARGE INTESTINE PERFORATION 22 0.0032
382 BLOOD LACTATE DEHYDROGENASE INCREASED 50 0.0032
383 HYPOXIA 111 0.0031
384 FUNGAL INFECTION 105 0.0031
385 NEPHROPATHY TOXIC 35 0.0031
386 CACHEXIA 16 0.0031
387 HAEMOLYSIS 24 0.0031
388 DRUG RESISTANCE 79 0.0031
389 VENOUS THROMBOSIS 12 0.0031
390 GASTROINTESTINAL INFECTION 27 0.0030
391 RESPIRATORY TRACT INFECTION VIRAL 7 0.0030
392 CHOLECYSTITIS ACUTE 17 0.0030
393 ANAL FISTULA 16 0.0030
394 CEREBRAL HAEMORRHAGE 107 0.0030
395 PYREXIA 1034 0.0030
396 PROCTALGIA 19 0.0030
397 RECURRENT CANCER 12 0.0029
398 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 11 0.0029
399 PLEURAL EFFUSION 173 0.0028
400 BRONCHIOLITIS 10 0.0028
401 LOWER GASTROINTESTINAL HAEMORRHAGE 21 0.0028
402 CLOSTRIDIUM DIFFICILE INFECTION 62 0.0028
403 CHRONIC MYELOID LEUKAEMIA 13 0.0028
404 HAEMORRHAGIC DIATHESIS 10 0.0028
405 ANAL FISSURE 15 0.0028
406 MOUTH HAEMORRHAGE 20 0.0027
407 SUPRAVENTRICULAR TACHYCARDIA 26 0.0027
408 AMYLASE INCREASED 10 0.0027
409 HYPERURICAEMIA 11 0.0027
410 CELLULITIS 134 0.0027
411 LUNG ADENOCARCINOMA 8 0.0027
412 RESPIRATORY TRACT INFECTION 69 0.0026
413 HYPERVOLAEMIA 13 0.0026
414 HAEMOGLOBIN DECREASED 270 0.0026
415 BLOOD POTASSIUM ABNORMAL 7 0.0026
416 IMMUNE THROMBOCYTOPENIA 12 0.0026
417 COLITIS 99 0.0026
418 BLOOD URIC ACID INCREASED 15 0.0026
419 ERYTHEMA MULTIFORME 24 0.0026
420 PERFORMANCE STATUS DECREASED 12 0.0026
421 TYPE IV HYPERSENSITIVITY REACTION 7 0.0026
422 LUNG INFECTION 39 0.0025
423 PNEUMONIA VIRAL 8 0.0025
424 C-REACTIVE PROTEIN INCREASED 91 0.0025
425 DRUG TOLERANCE DECREASED 7 0.0025
426 ABDOMINAL ABSCESS 11 0.0025
427 PANNICULITIS 6 0.0025
428 HYPERTRANSAMINASAEMIA 17 0.0024
429 RETINAL VEIN OCCLUSION 7 0.0024
430 ELECTROLYTE IMBALANCE 28 0.0024
431 BLOOD BILIRUBIN INCREASED 65 0.0024
432 DEVICE RELATED INFECTION 37 0.0024
433 COLITIS ISCHAEMIC 16 0.0024
434 HYPOMAGNESAEMIA 33 0.0024
435 STAPHYLOCOCCAL INFECTION 78 0.0024
436 HAEMODYNAMIC INSTABILITY 18 0.0024
437 MYOCARDITIS 27 0.0024
438 ACIDOSIS 18 0.0024
439 CARDIOTOXICITY 21 0.0024
440 ESCHERICHIA URINARY TRACT INFECTION 10 0.0024
441 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 6 0.0023
442 DIVERTICULITIS 64 0.0023
443 RED BLOOD CELL COUNT DECREASED 66 0.0023
444 HERPES SIMPLEX 15 0.0023
445 ELECTROCARDIOGRAM QT PROLONGED 83 0.0023
446 HAEMORRHAGIC STROKE 18 0.0023
447 CARDIOMYOPATHY 34 0.0023
448 TONSILLITIS 12 0.0023
449 UROSEPSIS 21 0.0023
450 HEPATIC CYTOLYSIS 29 0.0023
451 CHOLECYSTITIS 27 0.0023
452 UPPER GASTROINTESTINAL HAEMORRHAGE 38 0.0023
453 MENINGITIS 15 0.0022
454 MALIGNANT NEOPLASM PROGRESSION 230 0.0022
455 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 158 0.0022
456 HEPATITIS B REACTIVATION 7 0.0022
457 PETECHIAE 23 0.0022
458 GINGIVAL BLEEDING 30 0.0022
459 FAECALOMA 12 0.0022
460 ERYSIPELAS 11 0.0022
461 DEATH 1880 0.0022
462 SPINAL STENOSIS 9 0.0022
463 TOXIC ENCEPHALOPATHY 11 0.0022
464 EMBOLISM 18 0.0022
465 CARDIAC DYSFUNCTION 8 0.0021
466 NO THERAPEUTIC RESPONSE 26 0.0021
467 ACUTE LYMPHOCYTIC LEUKAEMIA 6 0.0021
468 FAILURE TO THRIVE 11 0.0021
469 HEPATOTOXICITY 47 0.0021
470 MYOCARDIAL ISCHAEMIA 24 0.0021
471 INTERVERTEBRAL DISC DISORDER 9 0.0021
472 CHRONIC LYMPHOCYTIC LEUKAEMIA 10 0.0021
473 PULMONARY TUBERCULOSIS 9 0.0021
474 TROPONIN INCREASED 16 0.0021
475 CHOLANGITIS 13 0.0021
476 CONJUNCTIVAL HAEMORRHAGE 8 0.0021
477 SUBCUTANEOUS ABSCESS 10 0.0021
478 NEOPLASM RECURRENCE 7 0.0021
479 DISEASE RECURRENCE 98 0.0021
480 CIRCULATORY COLLAPSE 35 0.0021
481 APPENDICITIS 19 0.0020
482 METABOLIC ENCEPHALOPATHY 6 0.0020
483 THROMBOPHLEBITIS 7 0.0020
484 CENTRAL VENOUS CATHETERISATION 6 0.0020
485 SUDDEN DEATH 21 0.0020
486 NEOPLASM PROGRESSION 69 0.0020
487 HAEMORRHAGE SUBCUTANEOUS 7 0.0020
488 FIBRIN D DIMER INCREASED 7 0.0020
489 GENERAL PHYSICAL HEALTH DETERIORATION 227 0.0020
490 THROMBOTIC MICROANGIOPATHY 19 0.0019
491 CARDIAC FAILURE 155 0.0019
492 MONOCYTE COUNT INCREASED 7 0.0019
493 BLOOD BLISTER 6 0.0019
494 CUTANEOUS VASCULITIS 7 0.0019
495 PLATELET COUNT INCREASED 25 0.0019
496 HERPES VIRUS INFECTION 11 0.0019
497 WHITE BLOOD CELL COUNT INCREASED 73 0.0019
498 ACUTE MYOCARDIAL INFARCTION 56 0.0019
499 MOUTH ULCERATION 40 0.0019
500 HYPOPHOSPHATAEMIA 14 0.0019
501 RALES 11 0.0019
502 STRESS CARDIOMYOPATHY 11 0.0019
503 TRANSAMINASES INCREASED 42 0.0019
504 GINGIVITIS 10 0.0019
505 OFF LABEL USE 1620 0.0018
506 OTITIS MEDIA 6 0.0018
507 ACUTE CORONARY SYNDROME 15 0.0018
508 SQUAMOUS CELL CARCINOMA 17 0.0018
509 EJECTION FRACTION DECREASED 28 0.0018
510 HEPATIC FUNCTION ABNORMAL 67 0.0018
511 ORAL INFECTION 7 0.0018
512 PROCEDURAL HAEMORRHAGE 7 0.0018
513 ANGIOPATHY 10 0.0018
514 OLIGURIA 11 0.0018
515 SUSPECTED OFF LABEL USE 8 0.0018
516 ACUTE KIDNEY INJURY 269 0.0018
517 LYMPHOCYTE COUNT DECREASED 31 0.0018
518 LUMBAR VERTEBRAL FRACTURE 8 0.0017
519 ISCHAEMIC STROKE 31 0.0017
520 MELAENA 38 0.0017
521 GASTROENTERITIS 25 0.0017
522 BLOOD LACTIC ACID INCREASED 9 0.0017
523 DELIRIUM 59 0.0017
524 ATRIAL FIBRILLATION 165 0.0017
525 HYPOGAMMAGLOBULINAEMIA 11 0.0017
526 HYPERPYREXIA 7 0.0017
527 ATRIOVENTRICULAR BLOCK COMPLETE 11 0.0016
528 CARDIAC FAILURE CHRONIC 7 0.0016
529 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 90 0.0016
530 ACUTE RESPIRATORY DISTRESS SYNDROME 29 0.0016
531 BLOOD TEST ABNORMAL 23 0.0016
532 TACHYPNOEA 22 0.0016
533 GENERALISED OEDEMA 20 0.0016
534 ILEUS 20 0.0016
535 HYPERNATRAEMIA 8 0.0016
536 EPISTAXIS 120 0.0016
537 CHRONIC SINUSITIS 6 0.0016
538 AUTOIMMUNE THYROIDITIS 6 0.0016
539 HYPOCALCAEMIA 30 0.0016
540 VENTRICULAR TACHYCARDIA 26 0.0016
541 TOOTH ABSCESS 16 0.0016
542 ILEUS PARALYTIC 7 0.0016
543 SKIN NECROSIS 8 0.0015
544 PERIPHERAL SENSORY NEUROPATHY 9 0.0015
545 ASCITES 45 0.0015
546 BUNDLE BRANCH BLOCK RIGHT 7 0.0015
547 TREATMENT FAILURE 126 0.0015
548 BLOOD CREATININE INCREASED 99 0.0015
549 LOCALISED OEDEMA 7 0.0015
550 ANURIA 13 0.0015
551 RESPIRATORY DISORDER 45 0.0015
552 GASTRITIS EROSIVE 7 0.0015
553 COAGULOPATHY 25 0.0015
554 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
555 HEPATITIS CHOLESTATIC 9 0.0015
556 HYPOPHAGIA 38 0.0015
557 COVID-19 260 0.0015
558 SHOCK HAEMORRHAGIC 12 0.0015
559 VIRAL UPPER RESPIRATORY TRACT INFECTION 7 0.0015
560 PERIPHERAL ISCHAEMIA 6 0.0015
561 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 14 0.0015
562 GASTROINTESTINAL HAEMORRHAGE 122 0.0015
563 RESPIRATORY DISTRESS 40 0.0014
564 ENCEPHALITIS 10 0.0014
565 SARS-COV-2 TEST POSITIVE 19 0.0014
566 STREPTOCOCCAL INFECTION 8 0.0014
567 LUNG DISORDER 69 0.0014
568 ENTERITIS 9 0.0014
569 CARDIOGENIC SHOCK 20 0.0014
570 CEREBRAL INFARCTION 34 0.0014
571 HEPATIC LESION 6 0.0014
572 HAEMOPTYSIS 38 0.0014
573 PULMONARY OEDEMA 61 0.0014
574 CORONAVIRUS INFECTION 9 0.0014
575 CEREBRAL ISCHAEMIA 7 0.0014
576 HEPATIC FAILURE 41 0.0014
577 SKIN MASS 9 0.0013
578 INTERSTITIAL LUNG DISEASE 65 0.0013
579 LOCALISED INFECTION 32 0.0013
580 STOMATITIS 80 0.0013
581 ADRENAL INSUFFICIENCY 16 0.0013
582 NEOPLASM 15 0.0013
583 RASH MACULO-PAPULAR 29 0.0013
584 HEMIPARESIS 22 0.0013
585 DIFFUSE LARGE B-CELL LYMPHOMA 10 0.0013
586 ORAL CANDIDIASIS 17 0.0013
587 TOXIC SKIN ERUPTION 13 0.0013
588 VASCULITIS 15 0.0013
589 DEEP VEIN THROMBOSIS 83 0.0013
590 DRUG-INDUCED LIVER INJURY 40 0.0013
591 HAEMATOMA 33 0.0013
592 HYPOVOLAEMIC SHOCK 6 0.0013
593 MALNUTRITION 14 0.0013
594 TOXIC EPIDERMAL NECROLYSIS 19 0.0012
595 PULMONARY HYPERTENSION 26 0.0012
596 FACE OEDEMA 21 0.0012
597 HUMERUS FRACTURE 6 0.0012
598 ANGINA UNSTABLE 8 0.0012
599 DECUBITUS ULCER 10 0.0012
600 PRODUCT USE ISSUE 230 0.0012
601 OEDEMA PERIPHERAL 148 0.0012
602 ABDOMINAL TENDERNESS 6 0.0012
603 HYPOVOLAEMIA 7 0.0012
604 LABORATORY TEST ABNORMAL 35 0.0012
605 WRONG PRODUCT ADMINISTERED 8 0.0012
606 HYPERTHERMIA 9 0.0012
607 HYPONATRAEMIA 66 0.0012
608 FEMORAL NECK FRACTURE 6 0.0012
609 RENAL IMPAIRMENT 98 0.0012
610 APHTHOUS ULCER 9 0.0012
611 METABOLIC ACIDOSIS 37 0.0012
612 LYMPHOEDEMA 8 0.0012
613 INGUINAL HERNIA 7 0.0011
614 AUTOIMMUNE HEPATITIS 8 0.0011
615 PARTIAL SEIZURES 6 0.0011
616 PULMONARY MASS 17 0.0011
617 CONJUNCTIVITIS 21 0.0011
618 LYMPHOPENIA 16 0.0011
619 HAEMORRHOIDS 22 0.0011
620 BODY TEMPERATURE INCREASED 23 0.0011
621 UPPER RESPIRATORY TRACT INFECTION 52 0.0011
622 RENAL TUBULAR NECROSIS 11 0.0011
623 HEPATOMEGALY 11 0.0011
624 HAEMOLYTIC ANAEMIA 10 0.0011
625 LOWER RESPIRATORY TRACT INFECTION 50 0.0011
626 UNEVALUABLE EVENT 83 0.0011
627 ASPIRATION 12 0.0011
628 CARDIAC ARREST 90 0.0011
629 MENTAL STATUS CHANGES 30 0.0011
630 SYNCOPE 108 0.0011
631 PANCREATITIS ACUTE 24 0.0011
632 PALLOR 29 0.0011
633 LIVER INJURY 26 0.0011
634 VIRAL INFECTION 35 0.0011
635 SINUS BRADYCARDIA 10 0.0010
636 RENAL FAILURE 136 0.0010
637 CYTOMEGALOVIRUS INFECTION 17 0.0010
638 ENCEPHALOPATHY 25 0.0010
639 BLOOD UREA INCREASED 17 0.0010
640 RESPIRATORY RATE INCREASED 9 0.0010
641 ANGINA PECTORIS 29 0.0010
642 HYPOTENSION 203 0.0010
643 HEPATITIS B 6 0.0010
644 ALANINE AMINOTRANSFERASE INCREASED 61 0.0010
645 GAMMA-GLUTAMYLTRANSFERASE INCREASED 22 0.0010
646 LIVER DISORDER 44 0.0010
647 TOOTH INFECTION 13 0.0010
648 BLOOD POTASSIUM INCREASED 16 0.0010
649 SKIN LESION 27 0.0010
650 POST PROCEDURAL INFECTION 8 0.0010
651 ASPARTATE AMINOTRANSFERASE INCREASED 52 0.0010
652 POLYURIA 8 0.0010
653 NEUTROPHIL COUNT INCREASED 10 0.0010
654 HAEMORRHAGE 102 0.0010
655 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
656 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
657 BLOOD ALKALINE PHOSPHATASE INCREASED 24 0.0010
658 HAEMATURIA 33 0.0010
659 CONSTIPATION 205 0.0009
660 PRODUCT USE IN UNAPPROVED INDICATION 232 0.0009
661 C-REACTIVE PROTEIN ABNORMAL 6 0.0009
662 CARDIO-RESPIRATORY ARREST 39 0.0009
663 BLOOD COUNT ABNORMAL 14 0.0009
664 HEPATITIS ACUTE 6 0.0009
665 AORTIC ANEURYSM 7 0.0009
666 INTENTIONAL PRODUCT USE ISSUE 80 0.0009
667 HAEMATOCRIT DECREASED 18 0.0009
668 HEPATIC CIRRHOSIS 17 0.0009
669 DRUG INTERACTION 142 0.0009
670 TORSADE DE POINTES 7 0.0009
671 GENERAL PHYSICAL CONDITION ABNORMAL 6 0.0009
672 DRUG LEVEL DECREASED 9 0.0009
673 HYPERKALAEMIA 31 0.0009
674 RHINITIS 7 0.0009
675 OEDEMA 47 0.0009
676 NEPHROPATHY 8 0.0009
677 DIARRHOEA HAEMORRHAGIC 8 0.0009
678 ASTHENIA 319 0.0008
679 CHOLESTASIS 16 0.0008
680 SHOCK 19 0.0008
681 PNEUMOTHORAX 13 0.0008
682 JAUNDICE 22 0.0008
683 STEVENS-JOHNSON SYNDROME 18 0.0008
684 URINARY TRACT INFECTION 138 0.0008
685 SKIN SWELLING 7 0.0008
686 ORTHOSTATIC HYPOTENSION 14 0.0008
687 HYDRONEPHROSIS 6 0.0008
688 NERVOUS SYSTEM DISORDER 25 0.0008
689 MITRAL VALVE INCOMPETENCE 9 0.0008
690 PEMPHIGOID 6 0.0008
691 PURPURA 7 0.0008
692 DRUG INEFFECTIVE 1026 0.0008
693 CHILLS 91 0.0008
694 TOOTHACHE 14 0.0008
695 GASTROINTESTINAL INFLAMMATION 6 0.0008
696 FOLLICULITIS 8 0.0008
697 BRAIN NEOPLASM 7 0.0008
698 PNEUMONIA ASPIRATION 19 0.0008
699 ORAL PAIN 17 0.0008
700 IMMUNE SYSTEM DISORDER 10 0.0008
701 DEPRESSED LEVEL OF CONSCIOUSNESS 30 0.0008
702 LOW BIRTH WEIGHT BABY 6 0.0008
703 ULCER 12 0.0008
704 TOXICITY TO VARIOUS AGENTS 126 0.0007
705 PRESYNCOPE 18 0.0007
706 DRUG ERUPTION 13 0.0007
707 SMALL INTESTINAL OBSTRUCTION 9 0.0007
708 DRUG INTOLERANCE 70 0.0007
709 DECREASED APPETITE 168 0.0007
710 DENTAL CARIES 8 0.0007
711 VENTRICULAR FIBRILLATION 8 0.0007
712 URINARY RETENTION 24 0.0007
713 ARRHYTHMIA 34 0.0007
714 POISONING 9 0.0007
715 DERMATITIS ALLERGIC 9 0.0007
716 HEPATITIS 18 0.0007
717 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
718 INFLAMMATION 36 0.0007
719 EMPHYSEMA 7 0.0007
720 GASTROINTESTINAL DISORDER 62 0.0007
721 NODULE 9 0.0007
722 PRODUCT PRESCRIBING ISSUE 15 0.0007
723 EPILEPSY 21 0.0007
724 DIARRHOEA 442 0.0007
725 CARDIAC DISORDER 64 0.0007
726 PULMONARY EMBOLISM 65 0.0007
727 HOSPITALISATION 105 0.0007
728 OXYGEN SATURATION DECREASED 38 0.0007
729 TENDERNESS 7 0.0007
730 HAEMATEMESIS 17 0.0007
731 INJECTION SITE REACTION 46 0.0007
732 OSTEOMYELITIS 12 0.0007
733 APHASIA 20 0.0007
734 OSTEOPENIA 10 0.0007
735 NEUROPATHY PERIPHERAL 62 0.0007
736 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
737 FAECES DISCOLOURED 14 0.0006
738 THERAPEUTIC RESPONSE DECREASED 39 0.0006
739 HEPATIC ENCEPHALOPATHY 6 0.0006
740 TACHYCARDIA 57 0.0006
741 VOMITING 299 0.0006
742 MUSCLE ATROPHY 8 0.0006
743 CYSTITIS 20 0.0006
744 NEUROTOXICITY 11 0.0006
745 ABSCESS 10 0.0006
746 NAUSEA 496 0.0006
747 BLOOD CALCIUM DECREASED 7 0.0006
748 NIGHT SWEATS 20 0.0006
749 EYE INFECTION 7 0.0006
750 LIVER FUNCTION TEST ABNORMAL 18 0.0006
751 HIATUS HERNIA 8 0.0006
752 ORAL HERPES 12 0.0006
753 CHOLELITHIASIS 20 0.0006
754 LIVER FUNCTION TEST INCREASED 13 0.0006
755 SPINAL FRACTURE 12 0.0006
756 SPINAL PAIN 7 0.0006
757 MALIGNANT MELANOMA 8 0.0006
758 CARDIOVASCULAR DISORDER 15 0.0006
759 ACUTE HEPATIC FAILURE 8 0.0006
760 CONFUSIONAL STATE 94 0.0006
761 FEMUR FRACTURE 18 0.0006
762 BASAL CELL CARCINOMA 9 0.0006
763 DERMATITIS 12 0.0006
764 MASS 8 0.0006
765 CONTUSION 55 0.0006
766 GASTRITIS 15 0.0006
767 HEAD INJURY 18 0.0006
768 SKIN REACTION 8 0.0006
769 BRADYCARDIA 30 0.0006
770 LYMPHADENOPATHY 20 0.0006
771 PHARYNGITIS 7 0.0006
772 SINUS TACHYCARDIA 8 0.0006
773 CONDITION AGGRAVATED 170 0.0006
774 RENAL DISORDER 26 0.0006
775 GOUT 10 0.0006
776 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
777 ABDOMINAL PAIN 129 0.0006
778 FLUID OVERLOAD 8 0.0005
779 PANCREATITIS 29 0.0005
780 INFLUENZA 61 0.0005
781 COMA 26 0.0005
782 ADVERSE DRUG REACTION 49 0.0005
783 PRODUCTIVE COUGH 26 0.0005
784 PRODUCT ADMINISTRATION ERROR 11 0.0005
785 DRUG LEVEL INCREASED 9 0.0005
786 HEPATIC STEATOSIS 10 0.0005
787 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 28 0.0005
788 RECTAL HAEMORRHAGE 23 0.0005
789 DEHYDRATION 71 0.0005
790 MICTURITION URGENCY 6 0.0005
791 THROMBOSIS 42 0.0005
792 GASTRIC HAEMORRHAGE 6 0.0005
793 HYPERGLYCAEMIA 19 0.0005
794 POST PROCEDURAL COMPLICATION 10 0.0005
795 FALL 170 0.0005
796 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
797 DYSPNOEA EXERTIONAL 19 0.0005
798 RHABDOMYOLYSIS 21 0.0005
799 HEPATOCELLULAR INJURY 7 0.0005
800 THERAPEUTIC PRODUCT EFFECT DECREASED 22 0.0005
801 PRODUCT PREPARATION ERROR 10 0.0005
802 HYPERCALCAEMIA 6 0.0005
803 GENERALISED TONIC-CLONIC SEIZURE 8 0.0005
804 PERITONITIS 10 0.0005
805 HYPOKINESIA 7 0.0005
806 BONE PAIN 28 0.0005
807 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 14 0.0005
808 FATIGUE 368 0.0005
809 SKIN HAEMORRHAGE 7 0.0005
810 COUGH 132 0.0005
811 COLON CANCER 7 0.0005
812 HEPATIC ENZYME INCREASED 32 0.0005
813 PULMONARY FIBROSIS 9 0.0005
814 ADVERSE EVENT 43 0.0005
815 BLOOD POTASSIUM DECREASED 14 0.0005
816 MULTI-ORGAN FAILURE 8 0.0005
817 DYSURIA 17 0.0005
818 DYSPNOEA 261 0.0005
819 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
820 DELUSION 7 0.0005
821 PRODUCT USE COMPLAINT 7 0.0004
822 CEREBROVASCULAR ACCIDENT 75 0.0004
823 ECZEMA 23 0.0004
824 PERIPHERAL COLDNESS 6 0.0004
825 PLASMA CELL MYELOMA 17 0.0004
826 HAEMATOCHEZIA 24 0.0004
827 CARDIAC FAILURE CONGESTIVE 34 0.0004
828 MUSCULOSKELETAL DISORDER 8 0.0004
829 NEOPLASM MALIGNANT 28 0.0004
830 FREQUENT BOWEL MOVEMENTS 11 0.0004
831 ARTHRITIS 32 0.0004
832 PRESCRIBED UNDERDOSE 8 0.0004
833 PREMATURE BABY 12 0.0004
834 RASH ERYTHEMATOUS 19 0.0004
835 TASTE DISORDER 8 0.0004
836 BRONCHITIS 29 0.0004
837 SKIN ULCER 10 0.0004
838 ANGIOEDEMA 17 0.0004
839 BACK PAIN 89 0.0004
840 HERPES ZOSTER 22 0.0004
841 SEIZURE 44 0.0004
842 OROPHARYNGEAL PAIN 35 0.0004
843 PREMATURE DELIVERY 6 0.0004
844 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
845 RASH 163 0.0004
846 URINARY INCONTINENCE 11 0.0004
847 PROTEINURIA 7 0.0004
848 SLEEP APNOEA SYNDROME 7 0.0004
849 BLOOD PRESSURE DECREASED 24 0.0004
850 BLOOD PRESSURE ABNORMAL 7 0.0004
851 MOBILITY DECREASED 25 0.0003
852 DYSPHAGIA 33 0.0003
853 INTESTINAL OBSTRUCTION 13 0.0003
854 HYPOTHYROIDISM 11 0.0003
855 DEAFNESS 9 0.0003
856 HIP FRACTURE 11 0.0003
857 SINUSITIS 35 0.0003
858 MUSCULAR WEAKNESS 38 0.0003
859 FLUID RETENTION 17 0.0003
860 HALLUCINATION 25 0.0003
861 HALLUCINATION, VISUAL 7 0.0003
862 MENTAL IMPAIRMENT 8 0.0003
863 SKIN DISORDER 11 0.0003
864 END STAGE RENAL DISEASE 6 0.0003
865 VERTIGO 20 0.0003
866 HYPERTENSION 69 0.0003
867 DYSPEPSIA 32 0.0003
868 DYSARTHRIA 12 0.0003
869 FRACTURE 6 0.0003
870 ABDOMINAL PAIN LOWER 8 0.0003
871 ERYTHEMA 64 0.0003
872 UNRESPONSIVE TO STIMULI 8 0.0003
873 WEIGHT DECREASED 86 0.0003
874 CHEST PAIN 57 0.0003
875 ANAPHYLACTIC REACTION 17 0.0003
876 DISORIENTATION 12 0.0003
877 DEPRESSED MOOD 16 0.0003
878 CYTOKINE RELEASE SYNDROME 6 0.0003
879 ABDOMINAL DISTENSION 31 0.0003
880 LIMB INJURY 8 0.0003
881 RHINORRHOEA 19 0.0003
882 MYOCARDIAL INFARCTION 50 0.0003
883 DEMENTIA 8 0.0003
884 MALAISE 125 0.0003
885 DIZZINESS 142 0.0003
886 OSTEOARTHRITIS 12 0.0003
887 OSTEONECROSIS OF JAW 7 0.0003
888 RENAL FAILURE ACUTE 12 0.0003
889 DRUG EFFECT INCOMPLETE 10 0.0003
890 CHEST DISCOMFORT 28 0.0003
891 ABDOMINAL DISCOMFORT 45 0.0003
892 COGNITIVE DISORDER 12 0.0003
893 HYPERHIDROSIS 33 0.0003
894 PERIPHERAL SWELLING 39 0.0003
895 LOSS OF CONSCIOUSNESS 32 0.0002
896 MUSCULOSKELETAL PAIN 13 0.0002
897 OSTEONECROSIS 8 0.0002
898 INFUSION RELATED REACTION 16 0.0002
899 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
900 CHRONIC KIDNEY DISEASE 18 0.0002
901 DIABETES MELLITUS 18 0.0002
902 GASTRIC DISORDER 8 0.0002
903 CORONARY ARTERY DISEASE 7 0.0002
904 DEPRESSION 52 0.0002
905 HEART RATE DECREASED 8 0.0002
906 GAIT DISTURBANCE 43 0.0002
907 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
908 DYSPHONIA 13 0.0002
909 HEART RATE INCREASED 22 0.0002
910 RASH PRURITIC 12 0.0002
911 LACTIC ACIDOSIS 7 0.0002
912 NECK PAIN 12 0.0002
913 ABDOMINAL PAIN UPPER 44 0.0002
914 BLISTER 12 0.0002
915 DISCOMFORT 13 0.0002
916 PAIN IN JAW 6 0.0002
917 PAIN IN EXTREMITY 62 0.0002
918 GAIT INABILITY 7 0.0002
919 MENTAL DISORDER 9 0.0002
920 ILLNESS 21 0.0002
921 WHEEZING 12 0.0002
922 TREATMENT NONCOMPLIANCE 11 0.0002
923 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
924 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
925 DYSKINESIA 8 0.0002
926 PRURITUS 74 0.0002
927 UNDERDOSE 14 0.0002
928 NO ADVERSE EVENT 34 0.0002
929 SWELLING 17 0.0002
930 LIP SWELLING 6 0.0002
931 COLITIS ULCERATIVE 8 0.0002
932 SKIN EXFOLIATION 15 0.0002
933 PAIN 109 0.0002
934 PROSTATE CANCER 14 0.0002
935 LETHARGY 10 0.0002
936 URTICARIA 29 0.0002
937 PALPITATIONS 20 0.0002
938 ARTHRALGIA 71 0.0002
939 BLADDER CANCER 10 0.0002
940 VISUAL IMPAIRMENT 21 0.0002
941 ALOPECIA 33 0.0002
942 POLLAKIURIA 7 0.0002
943 DYSGEUSIA 12 0.0002
944 SOMNOLENCE 32 0.0002
945 MYALGIA 26 0.0002
946 HEADACHE 95 0.0002
947 BALANCE DISORDER 13 0.0002
948 HYPOAESTHESIA 22 0.0001
949 LUNG NEOPLASM MALIGNANT 6 0.0001
950 MATERNAL EXPOSURE DURING PREGNANCY 13 0.0001
951 EXPOSURE DURING PREGNANCY 9 0.0001
952 WEIGHT INCREASED 32 0.0001
953 PARAESTHESIA 22 0.0001
954 SWELLING FACE 9 0.0001
955 AGITATION 10 0.0001
956 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
957 CATARACT 8 0.0001
958 SPEECH DISORDER 7 0.0001
959 BLOOD GLUCOSE INCREASED 25 0.0001
960 TREMOR 22 0.0001
961 FEELING HOT 8 0.0001
962 PRODUCT STORAGE ERROR 11 0.0001
963 HYPOGLYCAEMIA 6 0.0001
964 AMNESIA 8 0.0001
965 INCORRECT DOSE ADMINISTERED 28 0.0001
966 FEELING ABNORMAL 29 0.0001
967 INJECTION SITE ERYTHEMA 15 0.0001
968 IRRITABILITY 7 0.0001
969 INJURY 8 0.0001
970 SLEEP DISORDER 8 0.0001
971 INSOMNIA 30 0.0001
972 BLOOD PRESSURE INCREASED 17 0.0001
973 INFLUENZA LIKE ILLNESS 9 0.0001
974 ARTHROPATHY 6 0.0001
975 JOINT SWELLING 13 0.0001
976 DRY MOUTH 8 0.0001
977 MUSCLE SPASMS 18 0.0001
978 HYPERSENSITIVITY 18 0.0001
979 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
980 MUSCULOSKELETAL STIFFNESS 8 0.0001
981 ANXIETY 25 0.0001
982 NASOPHARYNGITIS 16 0.0001
983 PRODUCT QUALITY ISSUE 11 0.0001
984 FLUSHING 8 0.0001
985 MEMORY IMPAIRMENT 10 0.0001
986 INTENTIONAL PRODUCT MISUSE 6 0.0001
987 DRY SKIN 9 0.0001
988 VISION BLURRED 9 0.0001
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
990 MIGRAINE 6 0.0001
991 ASTHMA 7 0.0001
992 OVERDOSE 13 0.0001
993 INJECTION SITE PAIN 17 0.0001
994 EMOTIONAL DISTRESS 6 0.0000
995 PRODUCT DOSE OMISSION ISSUE 8 0.0000